Clinicopathological Features of Malignant Intraductal Papillary Mucinous Tumors of the Pancreas: The Differential Diagnosis from Benign Entities

Archives of Surgery

Volumn 139, Issue 2, 2004, Pages 188-192

  Kawai, Manabu ^a   Uchiyama, Kazuhisa ^a   Tani, Masaji ^a   Onishi, Hironobu ^a   Kinoshita, Hiroyuki ^a   Ueno, Masaki ^a   Hama, Takashi ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS TUMOR OF THE PANCREAS; MALIGNANT NEOPLASTIC DISEASE; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS JUICE; PANCREAS TUMOR; PATHOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADENOMA; AGED; BIOPSY, NEEDLE; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0842266668     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.2.188     Document Type: Article

References (32)

1. Cellir C, Cuillerrier E, Palazzo L, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc. 1998;47:42-49.
2. Nagai E, Ueki T, Chijiiwa K, Tanaka M, Tsuneyoshi M. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called mucinous ductal ectasia: histochemical and immunohistochemical analysis. Am J Surg Pathol. 1995;19:576-589.
3. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol. 1997;28:1010-1017.
4. Rivera JA, Fernandez del Castillo C, Pins M, et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms: a single malignant clinicopathologic entity. Ann Surg. 1997;225:637-644.
5. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection: comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717-722.
6. Sugiura H, Kondo S, Islam HK, et al. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2002;49:263-267.
7. Kanazumi N, Nakao A, Kaneko T, et al. Surgical treatment of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2001;48:967-971.
8. Yamano K, Ohashi K, Nakamura T, et al. The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology. 2000;47:1129-1134.
9. Tibayan F, Vierra M, Mindelzum B, et al. Clinical presentation of mucin-secreting tumors of the pancreas. Am J Surg. 2000;179:349-351.
10. Siech M, Tripp K, Rohlfing BS, Mattfeldt T, Gorich J, Beger HG. Intraductal papillary mucinous tumor of the pancreas. Am J Surg. 1999;177:117-120.
11. Loftus EV Jr, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology. 1996;110:1909-1918.
12. Yamao K, Ohashi K, Nakamura T, et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas. Hepatogastroenterology. 2001;48:962-966.
13. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes. Arch Surg. 1999;134:1131-1136.
14. Sugiyama M, Atomi Y, Kuroda A. Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment. Surgery. 1997;122:617-625.
15. Traverso LW, Peralta EA, Ryan JA Jr, Kozarek RA. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175:426-432.
16. Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer. 2001;91:35-41.
17. Niijima M, Yamaguchi T, Ishihara T, Hara T, Kato K, Kondo F, Saisho H. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2002;94:1565-1573.
18. Japan Pancreas Society. Classification of Pancreatic Carcinoma. Tokyo, Japan: Kanehara & Co Ltd; 2002.
19. Zweig MH, Gampell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
20. Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMango EP. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2002;97:2553-2558.
21. Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol. 2000;95:441-445.
22. Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P. Clinicopathological features and treatment of intraductal papillary mucinous tumors of the pancreas. Br J Surg. 2001;88:376-381.
23. Fukushima N, Mukai K, Sakamoto M, et al. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Virchows Arch. 2001;439:6-13.
24. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg. 1998;228:685-691.
25. Shima Y, Mori M, Takakura N, Kimura T, Yagi T, Tanaka N. Diagnosis and management of cystic pancreatic tumors with mucin production. Br J Surg. 2000;87:1041-1047.
26. Kubo H, Chijiiwa Y, Akahoshi K, et al. Intraductal papillary-mucinous tumors of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol. 2001;96:1429-1434.
27. Yamaguchi K, Ogawa Y, Chijiiwa K, Tanaka M. Mucin-hypersecreting tumor of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg. 1996;171:427-431.
28. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumors of the pancreas: clinical and therapeutic issues in 32 patients. Gut. 1996;39:457-464.
29. Kondo H, Sugano K, Fukayama N, et al. Detection of k-ras gene mutation at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer. 1997;79:900-905.
30. Futakawa N, Kimura W, Yamagata S, et al. Significance of k-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000;7:63-71.
31. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res. 1997;3:2479-2483.
32. Nakaizumi A, Uehara H, Takenaka A, et al. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. Hepatogastroenterology. 1999;46:31-37.